Viz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)
May 20 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:
VIZ.AI ANNOUNCES COLLABORATION WITH SANOFI AND REGENERON TO IMPROVE MANAGEMENT AND CARE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
VIZ.AI: WITH SUPPORT FROM SANOFI & REGENERON, VIZ.AI WILL INVESTIGATE USE OF VIZ COPD MODULE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.